Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks
NCT01756157
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema (HAE)
Interventions
BIOLOGICAL:
CINRYZE with rHuPH20
Sponsor
Shire